EGFR and cancer: Genetic aberrations (e.g. EGFR and MYC amplifications) in cancer cells also lead to dysregulated transcriptional programs which render cancer cells highly dependent upon exceptionally high rates of transcription of genes critical to promoting proliferation [6–8].